12 results
10-K
2019 FY
REPL
Replimune Group Inc
28 Jun 19
Annual report
5:10pm
providers. Recently, states have enacted or are considering legislation intended to make drug prices more transparent and deter significant price
DRS
bp5xw
3 May 18
Draft registration statement
12:00am
S-1
v1mfi6qr0jzhmv60d8
22 Jun 18
IPO registration
5:30pm
S-1/A
061 9jtau
26 Jun 18
IPO registration (amended)
5:24pm
DRS/A
3au2ndbfp17raw7ahc
11 Jun 18
Draft registration statement (amended)
12:00am
424B4
th5ahlr39
23 Jul 18
Prospectus supplement with pricing info
4:58pm
- Prev
- 1
- Next